The gut microbiome as a therapeutic target for pancreatic beta-cell preservation in type 1 diabetes

肠道微生物组作为 1 型糖尿病胰腺 β 细胞保存的治疗靶点

• 批准号: 476062
• 负责人: Jafari-Minab Rana
• 金额: $ 7.65万
• 依托单位: BC Children's Hospital Research Institute
• 依托单位国家: 加拿大
• 项目类别: Studentship Programs
• 财政年份: 2022
• 资助国家: 加拿大
• 起止时间: 2022-11-01 至 2025-11-01
• 项目状态: 未结题
• 来源: https://webapps.cihr-irsc.gc.ca/decisions/p/project_details.html?applId=476062&lang=en
• 关键词: Auto-Immunity; Fecal Microbiome Transplant; Microbiome; Treatment; Type 1 Diabetes

Type 1 diabetes (T1D) is an autoimmune disease in which the immune system attacks the insulin-producing cells of the pancreas, eventually destroying the body's ability to produce insulin. The causes of the immune attack are unknown. T1D has been linked to

1型糖尿病(T1D)是一种自身免疫性疾病，免疫系统攻击胰腺的胰岛素产生细胞，最终破坏身体产生胰岛素的能力。免疫攻击的原因尚不清楚。T1D已链接到